Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02927171 · ClinicalTrials.gov registry record · NA

Shifting Rehabilitation Paradigms in Skilled Nursing Facilities

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT02927171: Completed NA study, sponsored by VA Office of Research and Development.

NCT02927171 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02927171, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

This study seeks to improve rehabilitation methods for restoring physical function with skilled nursing facility care. More specifically, this study is designed to evaluate the effectiveness of an intensive therapeutic rehabilitation program for older adult skilled nursing home residents compared to usual care.

Primary Outcome

Global measure of lower extremity function, which consists of walking speed, chair stands, and balance tests. Minimum scores are 0 and maximum scores are 12. Higher scores indicate better function.

Interventions

  • OTHER IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2016-02-28
Est. Completion 2019-01-01
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02927171 record still lists

NCT02927171 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents is the first listed.

NCT02927171 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02927171 about?

NCT02927171 is a clinical study titled "Shifting Rehabilitation Paradigms in Skilled Nursing Facilities". This study seeks to improve rehabilitation methods for restoring physical function with skilled nursing facility care. More specifically, this study is designed to evaluate the effectiveness of an intensive therapeutic rehabilitation program for older adult skilled nursing home residents compared to...

What is the current status of trial NCT02927171?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2016-02-28. Estimated completion is 2019-01-01.

What interventions are being tested in trial NCT02927171?

The interventions under investigation include: IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents (OTHER).

Who is sponsoring clinical trial NCT02927171?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02927171's enrollment target sits among peer trials

104 836th of 2000 higher than 1,164 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02927171, the US trial registry maintained by the National Library of Medicine. NCT02927171 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.